Patients with hepatitis B can undergo IVF treatment provided that their liver function is normal and their hepatitis B virus titer is well controlled. Hepatitis B, referred to as hepatitis B, is an inflammatory disease of the liver caused by hepatitis B virus infection and is contagious. At present, there are more than 96 million hepatitis B virus carriers and more than 30 million hepatitis B-related liver disease patients nationwide, and 5-10% of carriers are pregnant women. Patients with hepatitis B are often accompanied by liver function damage, manifested as jaundice, elevated liver enzymes, coagulation dysfunction, decreased albumin levels, etc. In severe cases, ascites and hepatic encephalopathy can occur. IVF ovulation treatment requires the use of large amounts of ovulation-promoting drugs, which need to be metabolized by the liver. The liver is also required to metabolize the dramatic increase in estrogen and progesterone in the body. If liver function is abnormal, it will affect the action of the drugs and the determination of egg maturity, which in turn will affect the ovulation process. Although egg retrieval is a minimally invasive procedure, it is still invasive. If liver function is severely impaired in patients with hepatitis B, coagulation abnormalities may occur and the risk of intra-abdominal bleeding will be greatly increased; abnormal intra-operative drug metabolism will increase the burden on the liver, the accumulation of metabolic toxic substances and damage other organs. Keeping the viral titer at normal levels is very beneficial to the liver, liver function will be protected, and the infectivity of hepatitis B will be greatly reduced. This is a protection for the patient himself, as well as for the doctor and other patients. On the other hand, mother-to-child transmission is the main cause of chronic hepatitis B infection in China. By keeping maternal viral titers under normal control, the risk of hepatitis B infection in the newborn can be reduced. Of course, there are now many means of mother-to-child interruption, such as immunoglobulin B injections within 12 hours for newborns and the first dose of hepatitis B vaccine within 24 hours. After formal prophylaxis of the newborn, breastfeeding is feasible regardless of whether the pregnant woman is HBeAg negative or positive. The semen of men who are positive for hepatitis B virus surface antigen cannot cause hepatitis B virus infection in the fetus. There are also many hepatitis B patients who undergo IVF treatment. If you are a hepatitis B patient and need IVF treatment, you can undergo IVF treatment at our fertility center as long as your liver function is normal, your hepatitis B virus titer is at a normal level, and your hepatitis B condition is well controlled and there are no contraindications to treatment as certified by a doctor at a hospital specializing in infectious diseases.